^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

VAC2

i
Other names: AST-VAC2, VAC2
Associations
Company:
Cancer Research UK, Lineage Cell Therap
Drug class:
Immunostimulant, Telomerase inhibitor
Related drugs:
Associations
over1year
CRUKD/17/003: AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer (clinicaltrials.gov)
P1, N=9, Completed, Cancer Research UK | Active, not recruiting --> Completed | Trial completion date: Feb 2027 --> Aug 2022 | Trial primary completion date: Feb 2027 --> Aug 2022
Trial completion • Trial completion date • Trial primary completion date • Metastases
|
TERT (Telomerase Reverse Transcriptase)
|
VAC2